Noninvasive Ventilation (NIV): Types, Uses, and Monitoring

Noninvasive ventilation is a method of supporting breathing without inserting an endotracheal or tracheostomy tube. Respiratory assistance is delivered through an external interface, such as an oronasal mask, nasal mask, total-face mask, nasal pillows, helmet, or mouthpiece.

Depending on the mode selected, noninvasive ventilation can improve oxygenation, increase ventilation, reduce the work of breathing, and relieve respiratory distress.

When used in an appropriate patient and monitored closely, it may prevent intubation while avoiding many complications associated with invasive mechanical ventilation.

What Is Noninvasive Ventilation?

Noninvasive ventilation (NIV) refers to respiratory support provided without placing an artificial airway into the trachea. The patient continues to breathe through the natural upper airway while positive pressure is delivered through a mask or another external interface.

The term is often used specifically for noninvasive positive-pressure ventilation, although negative-pressure devices also provide noninvasive support. In most acute and chronic care settings, NIV refers to continuous positive airway pressure or bilevel positive airway pressure.

The main goals of noninvasive ventilation include:

• Improving alveolar ventilation
• Increasing oxygenation
• Reducing carbon dioxide retention
• Correcting respiratory acidosis
• Decreasing respiratory muscle workload
• Relieving dyspnea
• Preventing alveolar or upper-airway collapse
• Avoiding endotracheal intubation when possible

Noninvasive ventilation is not simply a less intensive form of mechanical ventilation. It requires careful patient selection, appropriate settings, a well-fitted interface, close monitoring, and early recognition of treatment failure.

How Noninvasive Ventilation Works

Positive-pressure ventilation assists breathing by increasing pressure at the airway opening. This pressure may be maintained continuously or changed between inspiration and expiration.

The effects depend on the type of support being delivered, the pressure levels selected, and the patient’s underlying condition.

Positive pressure can:

• Recruit collapsed alveoli
• Increase functional residual capacity
• Improve ventilation-perfusion matching
• Increase tidal volume
• Reduce inspiratory muscle effort
• Help overcome intrinsic positive end-expiratory pressure
• Maintain upper-airway patency
• Reduce cardiac preload and afterload in selected patients

Note: Patients with primarily oxygenation problems may benefit from continuous pressure. Patients with inadequate ventilation, elevated carbon dioxide, or respiratory muscle fatigue generally need inspiratory pressure assistance in addition to expiratory pressure.

Types of Noninvasive Ventilation

Continuous Positive Airway Pressure

Continuous positive airway pressure (CPAP) maintains one constant level of positive pressure throughout inspiration and expiration. The patient breathes spontaneously and receives no separate inspiratory pressure boost.

For example, a CPAP setting of 8 cm H₂O maintains approximately 8 cm H₂O of pressure during the entire respiratory cycle.

CPAP primarily helps by:

• Preventing alveolar collapse
• Increasing functional residual capacity
• Recruiting poorly ventilated lung regions
• Improving oxygenation
• Maintaining upper-airway patency
• Reducing left ventricular afterload in cardiogenic pulmonary edema

Because CPAP does not directly increase the pressure delivered during inspiration, it does not provide the same level of ventilatory assistance as bilevel ventilation. The patient remains responsible for generating each breath and performing most of the inspiratory work.

Note: CPAP is commonly used for obstructive sleep apnea, cardiogenic pulmonary edema, postoperative atelectasis, and selected forms of hypoxemic respiratory failure.

Bilevel Positive Airway Pressure

Bilevel positive airway pressure (BiPAP) is a form of noninvasive ventilation that delivers a higher pressure during inhalation and a lower pressure during exhalation to support breathing and improve ventilation.

It provides two pressure levels:

• Inspiratory positive airway pressure, or IPAP
• Expiratory positive airway pressure, or EPAP

IPAP is the higher pressure delivered during inspiration. EPAP is the lower pressure maintained during expiration. The difference between IPAP and EPAP is the pressure-support level.

For example:

• IPAP: 12 cm H₂O
• EPAP: 5 cm H₂O
• Pressure support: 7 cm H₂O

The pressure-support difference assists inspiration, increases tidal volume, reduces respiratory muscle effort, and improves carbon dioxide elimination.

EPAP functions similarly to CPAP or positive end-expiratory pressure. It helps maintain alveolar recruitment, stabilize small airways, improve oxygenation, and reduce the effort required to trigger a breath in patients with intrinsic PEEP.

Note: Bilevel ventilation is commonly used when the patient needs help with ventilation, especially in hypercapnic respiratory failure.

Spontaneous Mode

In a spontaneous mode, every supported breath must be triggered by the patient. The ventilator detects an inspiratory effort and delivers the selected IPAP.

This mode is appropriate when the patient has a reliable respiratory drive and can consistently trigger the device.

Spontaneous-Timed Mode

Spontaneous-timed mode supports patient-triggered breaths but also provides a backup respiratory rate. If the patient does not initiate a breath within a specified period, the device delivers a timed breath.

This mode may be useful for patients with:

• Central sleep apnea
• Neuromuscular weakness
• Unreliable respiratory effort
• Periods of apnea
• Central hypoventilation

Timed Mode

In a timed mode, breaths are delivered at a preset rate. The device does not rely entirely on the patient to trigger inspiration.

Timed ventilation may be used in selected chronic disorders, although successful noninvasive support still depends on maintaining airway protection and minimizing patient-device asynchrony.

Negative-Pressure Ventilation

Negative-pressure ventilation creates subatmospheric pressure around the chest or body. This causes the chest wall to expand and draws air into the lungs.

Examples include tank ventilators, cuirass devices, and other shell-like systems. These methods are less common in modern acute care but may still be used in selected patients with chronic neuromuscular or restrictive disorders.

Benefits of Noninvasive Ventilation

The major benefit of NIV is that it supports breathing while preserving the natural airway.

Endotracheal intubation can cause upper-airway trauma, vocal cord injury, discomfort, impaired swallowing, and an increased risk of ventilator-associated pneumonia. It may also require sedation and interfere with communication and eating.

Potential benefits of successful NIV include:

• Lower intubation rates
• Reduced airway trauma
• Less need for sedation
• Lower risk of ventilator-associated pneumonia
• Improved communication
• Preservation of swallowing
• Better ability to cough naturally
• Shorter duration of ventilatory support
• Reduced ICU or hospital length of stay
• Lower treatment costs
• Improved survival in selected patient groups

Note: These benefits are most likely when NIV is started early in an appropriate patient and produces clear clinical improvement.

Limitations of Noninvasive Ventilation

NIV does not secure or protect the airway. This creates several important limitations.

The clinician cannot suction the lower airway as easily as with an endotracheal tube. Patients with weak cough, excessive secretions, vomiting, or impaired airway protection may be unsafe candidates.

Other limitations include:

• Dependence on patient cooperation
• Difficulty maintaining a mask seal
• Air leakage
• Claustrophobia
• Pressure injuries
• Patient-ventilator asynchrony
• Gastric distention
• Limited access to the face and mouth
• Inability to provide reliable support in severe respiratory arrest

Note: NIV may also create a false sense of security if it is continued in a patient who is deteriorating. Delayed intubation is one of the most serious risks associated with unsuccessful treatment.

Common Indications for Noninvasive Ventilation

COPD Exacerbation

An acute exacerbation of chronic obstructive pulmonary disease is one of the best-established indications for bilevel ventilation.

During a severe exacerbation, increased airway resistance may lead to:

• Air trapping
• Dynamic hyperinflation
• Intrinsic PEEP
• Respiratory muscle fatigue
• Reduced alveolar ventilation
• Elevated PaCO₂
• Respiratory acidosis

Bilevel ventilation assists inspiration, increases tidal volume, reduces the work required to breathe, and improves carbon dioxide elimination.

A successful response is often reflected by:

• Lower respiratory rate
• Reduced accessory-muscle use
• Improved mental status
• Rising pH
• Falling PaCO₂
• Reduced dyspnea

Note: Treatment is more likely to succeed when it begins before profound exhaustion, severe acidosis, or loss of airway protection develops.

Acute Cardiogenic Pulmonary Edema

CPAP and bilevel ventilation are commonly used in acute cardiogenic pulmonary edema.

Positive pressure can:

• Recruit collapsed or fluid-filled alveoli
• Increase functional residual capacity
• Improve oxygenation
• Reduce venous return
• Decrease left ventricular afterload
• Reduce the work of breathing

CPAP may be appropriate when the primary problem is severe hypoxemia. Bilevel ventilation may be preferred when the patient also has hypercapnia, hypoventilation, or marked respiratory muscle fatigue.

Note: Patients with severe hypotension or unstable cardiac rhythms require cautious assessment because positive intrathoracic pressure can reduce venous return and cardiac output.

Obstructive Sleep Apnea

Obstructive sleep apnea occurs when the upper airway repeatedly narrows or collapses during sleep despite continued respiratory effort.

CPAP acts as a pneumatic splint by maintaining pressure within the upper airway. This helps prevent obstruction and can reduce:

• Apnea episodes
• Hypopneas
• Snoring
• Oxygen desaturation
• Sleep fragmentation
• Daytime sleepiness

Note: The pressure is commonly titrated during sleep testing or through an autotitrating device in selected patients.

Obesity Hypoventilation Syndrome

Patients with obesity hypoventilation syndrome may develop chronic daytime hypercapnia, sleep-related hypoventilation, and obstructive sleep apnea.

CPAP may be sufficient when upper-airway obstruction is the dominant problem. Bilevel ventilation may be needed when hypoventilation and carbon dioxide retention persist.

Neuromuscular Disease

Neuromuscular disorders can weaken the diaphragm and other respiratory muscles. Examples include:

• Amyotrophic lateral sclerosis
• Muscular dystrophy
• Spinal muscular atrophy
• Myasthenia gravis
• Other progressive neuromuscular conditions

Nocturnal hypoventilation may develop before obvious daytime respiratory failure. Symptoms may include morning headaches, fatigue, poor sleep, daytime sleepiness, and difficulty concentrating.

Nighttime NIV can rest respiratory muscles, improve ventilation during sleep, reduce carbon dioxide retention, and improve symptoms. In some progressive disorders, the need for support may gradually extend into daytime hours.

Chest-Wall and Restrictive Disorders

Patients with kyphoscoliosis or other severe chest-wall abnormalities may have reduced lung volumes and impaired ventilation. Long-term nocturnal NIV may improve gas exchange, sleep quality, and daytime function.

Postoperative Respiratory Dysfunction

Selected postoperative patients with atelectasis, hypoxemia, and reduced lung volumes may benefit from CPAP or bilevel ventilation.

NIV may help recruit the lungs, improve oxygenation, and reduce the risk of reintubation. It is less likely to succeed when the major problem is retained secretions, uncontrolled pain, aspiration, or severe hemodynamic instability.

Postextubation Support

NIV may be used after extubation in patients at high risk for recurrent respiratory failure.

It may be considered for patients with:

• COPD
• Chronic hypercapnia
• Heart failure
• Obesity hypoventilation
• Neuromuscular weakness
• Previous difficult weaning

Note: Preventive support after planned extubation may reduce respiratory deterioration in selected patients. However, NIV should not be continued when clear postextubation failure is present and reintubation is required.

Immunocompromised Patients

Avoiding intubation may be particularly valuable in immunocompromised patients because invasive ventilation can increase the risk of infection and other complications.

NIV may be considered when the patient has respiratory distress but remains cooperative, hemodynamically stable, and able to protect the airway.

Palliative Use

NIV may reduce dyspnea in patients who have chosen not to undergo intubation.

The goals of treatment must be clearly defined. NIV may be used as:

• A treatment intended to reverse respiratory failure
• A temporary trial with established limits
• A comfort-focused intervention to reduce breathlessness

Note: If the mask causes distress or interferes with communication, its burden may outweigh its benefit in comfort-focused care.

Conditions With Less Predictable Success

NIV may be attempted in selected patients with:

• Acute asthma
• Pneumonia
• Early acute respiratory distress syndrome
• Hypoxemic respiratory failure
• Bronchiolitis
• Cystic fibrosis
• Postoperative lung dysfunction

Note: The evidence and success rates are less consistent in these conditions than in COPD exacerbation or cardiogenic pulmonary edema. Patients with severe hypoxemia can deteriorate quickly. They require continuous reassessment and immediate access to intubation.

Patient Selection

Successful NIV begins with choosing the right patient.

An ideal candidate is:

• Breathing spontaneously
• Awake or easily arousable
• Cooperative
• Able to protect the airway
• Able to clear secretions
• Hemodynamically stable
• Able to tolerate the interface
• Likely to improve with short-term support

A reversible cause of respiratory distress and improvement during the first one to two hours are favorable signs.

Altered mental status is not always an absolute contraindication. A patient with hypercapnic encephalopathy may become more alert as ventilation improves. Such patients must be monitored closely, and intubation equipment should be immediately available.

Contraindications and Precautions

NIV is generally inappropriate in:

• Respiratory arrest
• Cardiac arrest
• Inability to protect the airway
• Active vomiting
• High aspiration risk
• Copious secretions
• Ineffective cough
• Severe hemodynamic instability
• Uncontrolled arrhythmias
• Major facial trauma
• Facial burns
• Recent facial surgery
• Severe upper-airway obstruction
• Inability to obtain an adequate mask seal
• Severe agitation
• Profoundly reduced consciousness
• Immediate need for intubation

Severe respiratory acidosis, refractory hypoxemia, worsening exhaustion, or progressive loss of consciousness suggest a high risk of failure.

A low pH does not automatically eliminate the possibility of NIV, but a pH below approximately 7.20 should raise serious concern and prompt preparation for invasive ventilation.

Interfaces Used for NIV

The interface affects comfort, leakage, pressure delivery, and patient acceptance.

Oronasal Mask

An oronasal mask covers the nose and mouth. It is commonly used during acute respiratory failure because distressed patients often breathe through the mouth.

Advantages include:

• Reduced mouth leak
• Better pressure delivery
• Improved ventilation during acute distress

Disadvantages include:

• Claustrophobia
• Difficulty communicating
• Aspiration concerns
• Pressure on the bridge of the nose

Nasal Mask

A nasal mask covers only the nose. It is commonly used for sleep-related and chronic therapy.

Advantages include:

• Greater comfort
• Easier communication
• Less facial coverage
• Better long-term tolerance for some patients

Note: Its main limitation is mouth leakage, which can reduce effective pressure and ventilation.

Nasal Pillows

Nasal pillows fit directly into the nostrils. They create minimal facial contact and may be comfortable for long-term CPAP users. They may be less effective at high pressures and can cause nasal dryness, soreness, or congestion.

Total-Face Mask

A total-face mask covers most of the face. It spreads pressure over a larger surface area and may reduce injury to the nasal bridge.

It may be helpful for:

• Mouth breathers
• Patients without teeth
• Patients with facial pressure injuries
• Patients who cannot tolerate an oronasal mask

Helmet Interface

A helmet surrounds the patient’s head and seals around the neck. It may reduce facial pressure injuries and improve tolerance in selected patients.

Its large internal volume may contribute to delayed pressure delivery, noise, and carbon dioxide rebreathing if flow and settings are inadequate.

Mouthpiece Ventilation

Mouthpiece ventilation may be used in selected patients with chronic neuromuscular weakness. It can provide daytime assistance while allowing speech, eating, and coughing between supported breaths.

Choosing and Fitting the Mask

The mask should be correctly sized and positioned before the straps are tightened.

An overly loose mask can cause:

• Large leaks
• Reduced pressure delivery
• Missed triggers
• Eye irritation
• Poor ventilation

An overly tight mask can cause:

• Pain
• Skin breakdown
• Nasal-bridge injury
• Claustrophobia
• Reduced tolerance

The goal is to obtain an adequate seal with the least strap tension necessary. Small leaks may be acceptable if the patient is comfortable and ventilation remains effective.

Protective dressings may be placed over pressure-sensitive areas. Alternating interfaces can reduce skin injury during prolonged treatment.

Ventilators and Circuits

NIV may be delivered through:

• Dedicated bilevel devices
• Critical-care ventilators with NIV modes
• Portable home ventilators
• Intermediate-care ventilators

Dedicated bilevel devices often use a single-limb circuit with an intentional leak port. Because there is no conventional exhalation valve, exhaled gas leaves through this port.

A minimum EPAP of approximately 3 to 5 cm H₂O is often needed to generate enough continuous flow to flush carbon dioxide from the circuit.

Some masks include an anti-asphyxia valve. This valve opens if the device loses power or pressure, allowing the patient to breathe room air. Acute-care ventilators may provide more precise oxygen delivery, extensive alarms, graphics, and advanced leak compensation.

Starting Noninvasive Ventilation

The patient should usually be positioned upright or with the head of the bed elevated. The procedure should be explained before the mask is applied. Anxiety can be reduced by allowing the patient to hold the mask briefly before the straps are secured.

Initial pressure should be introduced gradually.

A common starting approach for adult bilevel ventilation is:

• EPAP: 3 to 5 cm H₂O
• IPAP: 8 to 12 cm H₂O

Another frequently used starting range is:

• EPAP: 4 to 5 cm H₂O
• IPAP: 10 to 15 cm H₂O

These are starting points, not fixed prescriptions. Settings must be adjusted according to the patient’s disease, gas exchange, body size, comfort, work of breathing, tidal volume, leakage, and synchrony. Oxygen is added and adjusted to reach the prescribed saturation target.

Adjusting Pressure Settings

Increasing IPAP

Increasing IPAP widens the pressure-support difference when EPAP remains unchanged.

This generally:

• Increases tidal volume
• Improves minute ventilation
• Reduces PaCO₂
• Raises pH
• Decreases respiratory muscle workload

IPAP may need to be increased when:

• Tidal volume is low
• PaCO₂ remains elevated
• Respiratory acidosis persists
• Respiratory effort remains excessive
• The patient appears under-supported

Increasing EPAP

Increasing EPAP generally:

• Improves alveolar recruitment
• Raises functional residual capacity
• Improves oxygenation
• Stabilizes the upper airway
• Helps overcome intrinsic PEEP

EPAP may need to be increased when:

• Oxygenation remains inadequate
• Obstructive apnea persists
• Upper-airway collapse continues
• The patient has difficulty triggering because of intrinsic PEEP

If EPAP is increased without increasing IPAP, the pressure-support difference becomes smaller. This can reduce tidal volume and worsen carbon dioxide retention.

For example:

• Original settings: IPAP 14, EPAP 5
• Pressure support: 9 cm H₂O

If EPAP is increased to 8 while IPAP remains 14:

• New pressure support: 6 cm H₂O

Note: To maintain the original pressure support, IPAP would need to be increased to 17.

Increasing Both IPAP and EPAP

Increasing both pressures by the same amount may improve oxygenation while maintaining the same pressure-support difference. This can be useful when the patient needs additional expiratory pressure but should not lose inspiratory assistance.

Tidal Volume and Minute Ventilation

An exhaled tidal volume of approximately 4 to 6 mL/kg may be appropriate for many patients, although the ideal volume depends on the condition and treatment goals. Volume measurements during NIV may be inaccurate because of intentional and unintentional leakage.

The clinician should not rely on tidal volume alone. Respiratory rate, mental status, blood gases, chest movement, comfort, and work of breathing are equally important.

Monitoring During NIV

The first one to two hours are especially important because early response helps determine whether therapy is likely to succeed.

Monitoring should include:

• Respiratory rate
• Heart rate
• Blood pressure
• Oxygen saturation
• Mental status
• Dyspnea
• Accessory-muscle use
• Chest movement
• Breath sounds
• Tidal volume
• Mask leakage
• Skin condition
• Patient comfort
• Patient-ventilator synchrony
• Ability to clear secretions

Arterial blood gases may be obtained to assess:

• pH
• PaCO₂
• PaO₂
• Response to therapy

Note: Pulse oximetry cannot reliably detect hypoventilation, especially when supplemental oxygen is being delivered. A patient may maintain an acceptable oxygen saturation while carbon dioxide continues to rise.

Signs of Improvement

Successful treatment is usually associated with:

• Lower respiratory rate
• Reduced heart rate
• Less accessory-muscle use
• Improved comfort
• Reduced dyspnea
• Better alertness
• Improved oxygen saturation
• Increased tidal volume
• Rising pH
• Falling PaCO₂
• Improved synchrony

Note: Improvement should usually become apparent early. Continued support may be reasonable when the patient is clearly progressing toward the treatment goals.

Recognizing NIV Failure

NIV should be treated as a monitored therapeutic trial. It must not delay intubation when the patient is failing.

Warning signs include:

• Worsening respiratory distress
• Persistent or increasing tachypnea
• Rising PaCO₂
• Worsening acidosis
• Refractory hypoxemia
• Declining mental status
• Severe agitation
• Hemodynamic instability
• New arrhythmias
• Inability to clear secretions
• Vomiting
• Loss of airway protection
• Severe mask intolerance
• No meaningful improvement after an appropriate trial

Note: A patient who becomes exhausted, unstable, or less responsive requires immediate reassessment and preparation for invasive ventilation.

Air Leaks and Patient-Ventilator Asynchrony

Air leakage is one of the most common NIV problems.

Large leaks can:

• Reduce delivered pressure
• Lower tidal volume
• Prevent triggering
• Cause premature cycling
• Increase respiratory effort
• Irritate the eyes
• Produce inaccurate volume measurements

The first response should be to evaluate:

• Mask size
• Mask position
• Strap tension
• Tubing connections
• Mouth opening
• Interface type

The mask should be refitted or replaced before pressure is increased unnecessarily.

Asynchrony may also result from:

• Intrinsic PEEP
• Trigger sensitivity problems
• Insufficient inspiratory flow
• Excessive inspiratory time
• Inadequate pressure support
• Excessive pressure
• Poorly controlled leaks

Note: Visible patient effort that does not trigger the ventilator suggests ineffective triggering. A cautious increase in EPAP may help patients with COPD overcome intrinsic PEEP, provided adequate pressure support is maintained.

Humidification During NIV

Positive-pressure gas can cause:

• Nasal dryness
• Dry mouth
• Nasal congestion
• Thick secretions
• Sinus discomfort
• Reduced tolerance

Note: Active heated humidification may improve comfort during prolonged therapy. Heat-and-moisture exchangers are generally avoided during NIV because they can add resistance and dead space. This may interfere with triggering and increase carbon dioxide rebreathing.

Delivering Aerosolized Medications

Bronchodilators and other inhaled medications may be delivered during NIV.

Drug delivery depends on:

• The ventilator
• The circuit
• Mask leak
• Aerosol device placement
• Humidification
• Breathing pattern
• Interface type

Note: Medication effectiveness should be judged by the clinical response rather than assuming the entire dose reaches the lungs.

Complications of Noninvasive Ventilation

Common complications include:

• Facial discomfort
• Skin redness
• Nasal-bridge injury
• Pressure sores
• Eye irritation
• Nasal dryness
• Nasal congestion
• Dry mouth
• Claustrophobia
• Ear or sinus discomfort
• Gastric distention
• Sleep disruption
• Air leakage
• Patient-ventilator asynchrony

These problems may be managed by:

• Repositioning the mask
• Changing the interface
• Reducing strap tension
• Applying protective dressings
• Adjusting pressure
• Correcting leaks
• Adding heated humidification
• Using nasal saline
• Providing reassurance

Less common but more serious complications include:

• Aspiration
• Hypotension
• Pneumothorax
• Pressure-related lung injury
• Retained secretions
• Delayed intubation

Note: Pressures above approximately 20 cm H₂O may increase gastric insufflation in some patients, although the risk varies according to anatomy, mask seal, airway resistance, and lower esophageal sphincter function.

NIV in Infants and Children

Noninvasive ventilation may be used in pediatric patients with acute or chronic respiratory dysfunction.

Potential indications include:

• Bronchiolitis
• Pneumonia
• Atelectasis
• Asthma
• Postoperative respiratory failure
• Neuromuscular weakness
• Central hypoventilation
• Obesity-related hypoventilation
• Obstructive sleep apnea
• Postextubation support

The goals are similar to adult treatment:

• Reduce respiratory effort
• Improve oxygenation
• Increase ventilation
• Prevent intubation when appropriate

Pediatric patients require special attention to mask fit, triggering, respiratory rate, and inspiratory time. Infants and young children may generate inspiratory flows that are too small to trigger devices designed for adults. Rapid respiratory rates and short inspiratory times may also cause poor synchrony.

The clinician should verify that each patient effort results in an appropriate supported breath.

Signs of improvement include:

• Reduced respiratory rate
• Less nasal flaring
• Fewer retractions
• Improved chest movement
• Better oxygenation
• Improved carbon dioxide levels
• Greater comfort

Note: Some children with neuromuscular weakness may have severe hypercapnia without dramatic retractions or visible distress. Blood gas analysis or carbon dioxide monitoring may therefore be necessary.

Weaning and Discontinuing NIV

Weaning may begin when:

• The underlying cause is improving
• Respiratory distress has decreased
• Gas exchange is stable
• PaCO₂ and pH have improved
• Oxygen requirements are lower
• The patient can tolerate time without support
• Mental status is stable

NIV may be reduced by:

• Lowering IPAP
• Lowering EPAP
• Shortening treatment sessions
• Extending breaks
• Using support only during sleep
• Transitioning to supplemental oxygen

Note: Patients with acute illness may be discontinued completely once respiratory failure resolves. Patients with chronic neuromuscular disease, obesity hypoventilation, or restrictive disorders may continue nighttime support even when daytime assistance is no longer needed.

Noninvasive Ventilation Practice Questions

1. What is noninvasive ventilation?
Noninvasive ventilation is a method of supporting breathing without inserting an endotracheal or tracheostomy tube.

2. How is respiratory support delivered during noninvasive ventilation?
Respiratory support is delivered through an external interface, such as an oronasal mask, nasal mask, total-face mask, helmet, or mouthpiece.

3. What are the two main forms of noninvasive positive-pressure ventilation?
The two main forms are continuous positive airway pressure and bilevel positive airway pressure ventilation.

4. What does CPAP provide throughout the respiratory cycle?
CPAP provides one constant level of positive pressure during both inspiration and expiration.

5. Does CPAP provide a separate inspiratory pressure boost?
No. CPAP does not provide a separate inspiratory pressure boost.

6. What is the primary purpose of CPAP?
The primary purpose of CPAP is to improve oxygenation by maintaining airway and alveolar patency.

7. What does IPAP stand for?
IPAP stands for inspiratory positive airway pressure.

8. What does EPAP stand for?
EPAP stands for expiratory positive airway pressure.

9. How is pressure support calculated during bilevel ventilation?
Pressure support is calculated by subtracting EPAP from IPAP.

10. What is the pressure-support level when IPAP is 12 cm H₂O and EPAP is 5 cm H₂O?
The pressure-support level is 7 cm H₂O.

11. What usually happens when IPAP is increased while EPAP remains unchanged?
Tidal volume, minute ventilation, and carbon dioxide elimination usually increase.

12. What is the main effect of increasing EPAP?
Increasing EPAP can improve oxygenation and help maintain airway and alveolar stability.

13. Why can increasing EPAP reduce tidal volume if IPAP is unchanged?
Increasing EPAP narrows the difference between IPAP and EPAP, which reduces pressure support.

14. What is one of the strongest indications for bilevel noninvasive ventilation?
One of the strongest indications is an acute COPD exacerbation with hypercapnic respiratory failure.

15. How does bilevel ventilation help a patient with a COPD exacerbation?
It reduces respiratory muscle workload, increases tidal volume, improves alveolar ventilation, and lowers PaCO₂.

16. What clinical changes suggest improvement in a patient with COPD receiving NIV?
A lower respiratory rate, reduced accessory-muscle use, rising pH, and falling PaCO₂ suggest improvement.

17. Why is positive airway pressure useful in acute cardiogenic pulmonary edema?
It improves oxygenation, recruits alveoli, reduces venous return, and decreases left ventricular afterload.

18. When may bilevel ventilation be preferred over CPAP in cardiogenic pulmonary edema?
Bilevel ventilation may be preferred when the patient also has hypercapnia, hypoventilation, or significant respiratory muscle fatigue.

19. What characteristics make a patient a good candidate for NIV?
A good candidate is spontaneously breathing, cooperative, able to protect the airway, able to manage secretions, and hemodynamically stable.

20. Why is the ability to protect the airway important during NIV?
NIV does not secure the airway, so the patient must be able to prevent aspiration and manage secretions.

21. In what situation is NIV clearly contraindicated?
NIV is clearly contraindicated in respiratory or cardiac arrest.

22. Why can active vomiting make NIV unsafe?
Active vomiting increases the risk of aspiration because the airway is not protected by a cuffed tube.

23. Why can excessive secretions cause NIV failure?
Excessive secretions may obstruct airflow and cannot be suctioned as easily without an artificial airway.

24. Which interface is commonly preferred in acute respiratory failure?
An oronasal mask is commonly preferred because acutely distressed patients often breathe through the mouth.

25. Why must NIV failure be recognized promptly?
Delayed intubation in a deteriorating patient can worsen outcomes and increase the risk of complications.

26. What is the main advantage of NIV compared with invasive mechanical ventilation?
NIV supports breathing while preserving the natural airway and avoiding complications associated with endotracheal intubation.

27. How can NIV reduce the risk of ventilator-associated pneumonia?
It avoids placement of an artificial airway, which reduces exposure to one of the major risk factors for ventilator-associated infection.

28. Why is less sedation usually required during NIV?
The patient remains awake and breathes through a mask rather than an endotracheal tube, so deep sedation is often unnecessary.

29. What is functional residual capacity?
Functional residual capacity is the volume of air remaining in the lungs after a normal exhalation.

30. How does CPAP increase functional residual capacity?
CPAP maintains positive pressure at the end of expiration, helping keep alveoli open and increasing the amount of air remaining in the lungs.

31. What is intrinsic PEEP?
Intrinsic PEEP is positive pressure that remains in the lungs at the end of expiration because of incomplete exhalation and air trapping.

32. How can EPAP help a patient with intrinsic PEEP?
EPAP can reduce the pressure difference the patient must overcome to trigger a supported breath.

33. What is hypercapnic respiratory failure?
Hypercapnic respiratory failure is inadequate ventilation that causes an elevated arterial carbon dioxide level, often with respiratory acidosis.

34. What blood gas change indicates that NIV is improving hypercapnic respiratory failure?
A falling PaCO₂ and rising pH indicate improved ventilation and correction of respiratory acidosis.

35. What is the role of supplemental oxygen during NIV?
Supplemental oxygen is adjusted to help the patient reach the prescribed oxygen saturation target.

36. Why should pulse oximetry not be used as the only measure of NIV effectiveness?
Pulse oximetry measures oxygenation but may not detect worsening hypoventilation or rising carbon dioxide levels.

37. Why may arterial blood gases be obtained after NIV begins?
Arterial blood gases help determine whether pH, PaCO₂, and oxygenation are improving.

38. When should improvement from acute NIV usually become apparent?
Meaningful clinical improvement should usually appear within the first one to two hours.

39. What does persistent tachypnea during NIV suggest?
Persistent tachypnea may indicate inadequate support, worsening respiratory failure, poor tolerance, or treatment failure.

40. What does declining consciousness during NIV indicate?
Declining consciousness may indicate worsening hypercapnia, hypoxemia, fatigue, or loss of airway protection.

41. Why is severe hemodynamic instability a contraindication to NIV?
Positive pressure may reduce venous return and worsen blood pressure or cardiac output in an unstable patient.

42. What is the purpose of an anti-asphyxia valve?
An anti-asphyxia valve opens if pressure or power is lost so the patient can breathe room air.

43. Why is a continuous leak port used in many single-limb NIV circuits?
The leak port allows exhaled gas to leave the circuit and helps reduce carbon dioxide rebreathing.

44. Why is a minimum EPAP often required in a single-limb NIV circuit?
A minimum EPAP helps generate enough continuous flow to flush exhaled carbon dioxide from the circuit.

45. Why should the mask be introduced gradually?
Gradual application can reduce anxiety, claustrophobia, and resistance to treatment.

46. What position is commonly used when starting NIV?
The patient is usually placed upright or with the head of the bed elevated.

47. Why should the patient sometimes be allowed to hold the mask before it is secured?
Holding the mask can help the patient become familiar with the interface and improve tolerance.

48. What can happen if the mask straps are overtightened?
Overtightened straps can cause pain, skin breakdown, pressure injury, and reduced tolerance.

49. What can happen if the mask is too loose?
A loose mask can cause excessive leakage, poor triggering, reduced pressure delivery, and eye irritation.

50. Why may a total-face mask be chosen instead of an oronasal mask?
A total-face mask may distribute pressure more evenly and reduce injury to the bridge of the nose.

51. When is a nasal mask most commonly used for NIV?
A nasal mask is most commonly used for stable, long-term, or sleep-related therapy.

52. What is a common limitation of using a nasal mask?
Air may leak through the mouth, reducing effective pressure and ventilation.

53. What are nasal pillows?
Nasal pillows are small cushions that fit into the nostrils to deliver positive airway pressure with minimal facial contact.

54. Why may nasal pillows be unsuitable for higher pressure requirements?
They may become uncomfortable or fail to maintain an effective seal when higher pressures are needed.

55. What is one potential advantage of a helmet interface?
A helmet may reduce facial pressure injuries and improve comfort in selected patients.

56. What problem can occur because of the large internal volume of a helmet?
The large internal volume may contribute to carbon dioxide rebreathing if flow and pressure are inadequate.

57. In which patients may mouthpiece ventilation be useful?
Mouthpiece ventilation may be useful in selected patients with chronic neuromuscular weakness who need daytime support.

58. What is the purpose of a backup respiratory rate during bilevel ventilation?
A backup rate delivers timed breaths when the patient does not breathe frequently enough.

59. Which patients may benefit from a spontaneous-timed mode?
Patients with central apnea, unreliable respiratory effort, or neuromuscular weakness may benefit from spontaneous-timed ventilation.

60. Why can patient-triggering be difficult in infants and small children?
Their inspiratory efforts may be too weak or brief for the ventilator to detect reliably.

61. What should the clinician observe when assessing synchrony in a child receiving NIV?
The clinician should confirm that each inspiratory effort triggers a supported breath and that cycling occurs at the appropriate time.

62. What does premature cycling mean during NIV?
Premature cycling occurs when the ventilator ends inspiration before the patient has completed the inspiratory effort.

63. What does delayed triggering mean?
Delayed triggering occurs when the ventilator provides support only after the patient has already made a significant inspiratory effort.

64. How can a large leak affect ventilator triggering?
A large leak can prevent the ventilator from recognizing the patient’s inspiratory effort.

65. What should be checked first when a large mask leak is detected?
Mask position, size, strap tension, tubing connections, and mouth leakage should be checked first.

66. Why should pressure not be increased immediately to compensate for every leak?
Higher pressure may worsen the leak, increase discomfort, and create additional asynchrony.

67. What is gastric insufflation?
Gastric insufflation is the entry of pressurized air into the stomach during positive-pressure therapy.

68. What symptoms may result from gastric insufflation?
It may cause abdominal discomfort, bloating, nausea, or increased aspiration risk.

69. Why can positive pressure cause hypotension?
Positive intrathoracic pressure can reduce venous return to the heart and lower cardiac output.

70. What is a common cause of eye irritation during NIV?
Air leaking upward from the mask toward the eyes commonly causes irritation.

71. How can nasal or oral dryness during NIV be managed?
Heated humidification, nasal saline, and correction of excessive leak may improve dryness.

72. Why are heat-and-moisture exchangers generally avoided during NIV?
They add resistance and dead space, which may increase the work of breathing and carbon dioxide rebreathing.

73. What is one reason aerosol medication delivery may be inconsistent during NIV?
Mask leaks and circuit configuration can reduce the amount of medication reaching the lungs.

74. When may NIV be used for a patient who does not want intubation?
It may be used to reverse a treatable episode or reduce dyspnea when this approach matches the patient’s goals of care.

75. What should be clarified before using NIV as a palliative intervention?
The care team should clarify whether the goal is recovery, a limited treatment trial, or relief of breathlessness.

76. How can NIV help patients with nocturnal hypoventilation?
NIV can improve ventilation during sleep, reduce carbon dioxide retention, rest respiratory muscles, and improve sleep-related symptoms.

77. What symptoms may suggest nocturnal hypoventilation?
Morning headaches, daytime sleepiness, fatigue, poor sleep, and difficulty concentrating may suggest nocturnal hypoventilation.

78. Why may patients with neuromuscular disease need NIV before daytime respiratory failure appears?
Respiratory muscle weakness may first cause inadequate ventilation during sleep, when breathing naturally becomes less effective.

79. How can long-term NIV benefit patients with chest-wall deformities?
It can improve nocturnal ventilation, reduce chronic carbon dioxide retention, improve sleep quality, and support daytime function.

80. When may CPAP be sufficient for obesity hypoventilation syndrome?
CPAP may be sufficient when obstructive sleep apnea and upper-airway collapse are the dominant problems.

81. When may bilevel ventilation be needed in obesity hypoventilation syndrome?
Bilevel ventilation may be needed when hypoventilation and hypercapnia persist despite treatment of upper-airway obstruction.

82. How may NIV help selected postoperative patients?
It may recruit collapsed alveoli, improve oxygenation, reduce respiratory effort, and lower the risk of reintubation.

83. Why may NIV be less effective when postoperative respiratory failure is caused by retained secretions?
NIV does not provide direct access to the lower airway for suctioning and may not correct secretion-related obstruction.

84. What is preventive postextubation NIV?
Preventive postextubation NIV is support started after planned extubation in a high-risk patient to reduce the chance of recurrent respiratory failure.

85. Why should NIV not be used to delay reintubation after extubation failure?
Delaying reintubation may allow respiratory fatigue, hypoxemia, acidosis, or loss of airway protection to worsen.

86. Why may immunocompromised patients benefit from avoiding intubation?
Avoiding an artificial airway may reduce their exposure to pneumonia and other complications of invasive ventilation.

87. Why is NIV success less predictable in severe pneumonia?
Pneumonia may cause progressive hypoxemia, heavy secretion production, and rapidly worsening lung dysfunction that noninvasive support cannot fully correct.

88. Why must patients with early acute respiratory distress syndrome be monitored especially closely during NIV?
Their oxygenation can deteriorate rapidly, creating an urgent need for intubation and lung-protective invasive ventilation.

89. How can excessive CPAP affect a patient with hyperinflation?
Excessive CPAP may worsen lung overdistention, increase air trapping, and reduce tidal volume.

90. How can CPAP improve tidal volume in restrictive lung disease?
By recruiting collapsed lung tissue and improving lung volume, CPAP may allow more effective spontaneous breaths.

91. What is the purpose of a ramp feature on a CPAP device?
A ramp feature begins at a lower pressure and gradually increases to the prescribed pressure to improve comfort while the patient falls asleep.

92. What is autotitrating CPAP?
Autotitrating CPAP is a mode that automatically adjusts pressure in response to signals of upper-airway obstruction.

93. Why may autotitrating CPAP be inappropriate for some patients?
Central apnea, prolonged hypoventilation, heart failure, severe leakage, or other complex conditions may interfere with safe and accurate automatic pressure adjustment.

94. What is the apnea-hypopnea index?
The apnea-hypopnea index is the average number of apnea and hypopnea episodes occurring during each hour of sleep.

95. How does positive airway pressure treat obstructive sleep apnea?
It acts as a pneumatic splint that helps prevent the upper airway from collapsing during sleep.

96. What factors should be stable before NIV weaning begins?
The underlying condition, gas exchange, respiratory effort, mental status, and oxygen requirements should be stable or improving.

97. How can NIV be weaned in an acutely ill patient?
Pressure levels may be reduced, treatment sessions shortened, and progressively longer periods without support introduced.

98. Why may a chronic NIV user continue nighttime therapy after daytime support is stopped?
Sleep-related hypoventilation may persist even when daytime breathing has improved.

99. What is the greatest danger of continuing ineffective NIV?
The greatest danger is delayed recognition of worsening respiratory failure and delayed intubation.

100. What factors are most important for successful noninvasive ventilation?
Successful NIV depends on proper patient selection, an appropriate interface, suitable pressure settings, effective leak control, close monitoring, and early recognition of failure.

Final Thoughts

Noninvasive ventilation (NIV) can improve oxygenation, ventilation, and respiratory comfort without requiring an artificial airway. Its strongest acute applications include COPD exacerbations with hypercapnic respiratory failure and acute cardiogenic pulmonary edema, while long-term use benefits selected patients with sleep apnea, obesity hypoventilation, neuromuscular weakness, and restrictive chest-wall disease.

Success depends on choosing a suitable patient, selecting and fitting the interface correctly, adjusting pressure according to the clinical problem, and monitoring the response closely. Most importantly, clinicians must recognize failure early and proceed with intubation when noninvasive support is no longer safe or effective.